|
 Viewing Category

Entries for the 'Pharmacetical Drug Litigation' Category

Jon Gelman Listed in Best Lawyers in America 2015

Jon Gelman has been listed again to Best Lawyers in America®. This recognition has been bestowed upon him for almost 2 decades. 

Jon L. Gelman on the Super Lawyers List for 2014

Jon L. Gelman has been named to the 2014 edition of New Jersey Super Lawyers. Each year, only 5 percent of the lawyers in the state receive this honor.

 The list is published by Martindale-Hubbell®, a company rates lawyers and designates an AV® Preeminent TM Peer Review Rating, the highest rating in legal ability and ethical standards.

Spine Epidurals: Multistate Meningitis Outbreak Investigation

The US Centers for Disease Control (CDC) is coordinating a multistate investigation of meningitis among patients who received epidural steroid injections (medication injected into the spine).

Social Media to Expand Your Workers' Compensation Practice: Jason Gelman Speaks At AAJ Convention

How to use social media to expand your workers' compensation practice was the subject of a presentation by Jason Gelman at the American Association of Justice's annual convention in Chicago.

Jon Gelman Rated "Superb" by Avvo

 Jon L. Gelman has received the top rating of "Superb" from Avvo. The rating indicated a perfect score in: experience, industry recognition and professional conduct.

Injured From the Side Effects of Tektuna? Contact Us Now.....

Tekturna®, a blood pressure drug, has been associated with potentially life-threatening side effects such as stroke, kidney injury, high potassium and low blood pressure.

In December 2011, Tekturna® manufacturer Novartis announced its decision to terminate the clinical ALTITUDE study of the blood pressure drug based on the recommendation of the independent Data Monitoring Committee (DMC) overseeing the clinical trial study. 

 Following a November 2011 warning issued by the European Medicines Agency (EMA), the Food and Drug Administration (FDA) decided to reevaluate the safety of Pradaxa®. 

FDA Votes to Restrict Avandia Due to Risks

Jon L Gelman is investigating cases involving individuals who have suffered a heart attack, ischemic stroke or other cardiac condition while taking Avandia for diabetes.

Jon Gelman is investigating cases involving infant drugs manufactured by pharmaceutical company McNeil Consumer Healthcare including include certain liquid infant’s and children’s Tylenol®, Motrin®, Zyrtec®, and Benadryl® products.

Jon Gelman is investigating cases involving Paxil users who have a child who suffered birth malformations after being exposed to Paxil within any trimester of pregnancy. Paxil and Paxil CR® are antidepressants manufactured by the pharmaceutical company GlaxoSmithKline.

FDA Requires  Botox®  Maker to Notify of Potential Adverse Effects

 FDA requires manufacturer of Botox® to post warning on its product of potential adverse reactions.

Medtronic Paradigm® Quick-set® Infusion Sets Recalled Due to Potential Injuries

On July 10, 2009, Medtronic, Inc., announced a defect in the Paradigm® Quick-Set® Infusion Sets. The company identified a potentially high rate of failure of the system to function properly and deliver medication to the patient in an accurate manner through the pump.

Levaquin®  Treatment Reactions  Causes FDA To Require Warning

In July 2008, the FDA announced a mandatory black box warning label for fluoroquinolone drugs that highlights and strengthens the warning for increased risk of tendonitis and tendon rupture

FDA Alerts Consumers Concering Zicam®

Jon L. Gelman LLC is investigating cases involving individuals who have suffered the loss of taste and smell (anosmia) after using Zicam®. Zicam® is an over-the-counter nasal spray used to relieve the symptoms associated with the common cold and flu and is manufactured by Matrixx Initiatives. Matrixx manufactures a range of products under the Zicam® name, but the name Zicam® is generally used to refer to its over-the-counter nasal zinc solution spray.  

Raptiva® Withdrawn From Market for High Risk of Fatal Brain Disease

We are investigating cases in which Raptiva® users have experienced neurological changes including unusual weakness, loss of coordination and changes in vision.

On April 8, 2009, the drug manufacturer Genentech announced a phased withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. market.
 

The Compensability of a Swine Flu Pandemic

The US Centers for Disease Control (CDC) has issued an alert for the spread of human swine flu virus. Employers and employees will now need to be alerted to preparations and the reactions that may occur.

Hydroxycut® Products Withdrawn From Market After FDA Consumer Advisory Warning
Jon L. Gelman  is investigating potential cases involving users of Hydroxycut® products who have experienced health problems that may include Rha...
Grease Removers Recalled by Fantastic Distributors Due to Chemical Burn Hazard

 The U.S. Consumer Product Safety Commission, in cooperation with the firm named below, today announced a voluntary recall of "Bagi Shumanit" Super Cold Grease Removers. Consumers should stop using recalled products immediately unless otherwise instructed.

Page 1 of 2First   Previous   [1]  2  Next   Last   
Copyright 2014 by Jon Gelman, LLC - Attorney at Law. All rights reserved.   |  Privacy Statement  |  Terms Of Use